Pamela E. ARMSTRONG, Appellant,
v.
AETNA LIFE INSURANCE COMPANY, Aetna Health Plan, Plan
Administrator, Appellees.
No. 97-1712.
United States Court of Appeals,
Eighth Circuit.
Submitted Sept. 8, 1997.
Decided Nov. 13, 1997.
Rehearing and Suggestion for Rehearing En Banc Denied Dec.
19, 1997.*
M. Kevin Underhill, Kansas City, MO, argued, for appellant.
John W. Cowden, Kansas City, MO, argued (Patricia Rosa, Kansas City, MO, on the brief), for appellees.
Before RICHARD S. ARNOLD, Chief Judge, and HEANEY and BEAM, Circuit Judges.
HEANEY, Circuit Judge.
Pamela E. Armstrong appeals the district court's grant of summary judgment in favor of Aetna Life Insurance Company, Aetna Health Plan, and Plan Administrator (collectively "Aetna") on Armstrong's claim that Aetna wrongfully denied her benefits under a health plan administered by Aetna and governed by the Employee Retirement Security Income Act, 29 U.S.C. § 1001 ("ERISA"). We affirm.
I.
In May 1993, Armstrong was diagnosed with leukemia. She underwent chemotherapy for the disorder after which the leukemia went into remission in October 1993. At the time, Armstrong had health-care coverage through a group health plan administered by Travelers Insurance Company. On May 1, 1995, Armstrong left her residence in Colorado, taking a job with a realtor in Kansas City. The realtor offered Armstrong a group health plan insured by Aetna. Aetna also administers the plan, and, by the terms of the health plan agreement, Aetna has the discretion to review claims. Armstrong transferred her coverage to the Aetna plan, becoming eligible for benefits under the plan on June 1, 1995.
On March 7, 1995, Armstrong visited Dr. Pamela Perry, a primary care doctor, to "get established with a new physician." After Armstrong informed Dr. Perry of her history of leukemia, Dr. Perry ordered a complete blood count, which was performed the next day. The test indicated a white blood count that Dr. Perry described as "abnormal" and " low." Based on the test results and Armstrong's medical history, Dr. Perry ordered a more detailed test called a "peripheral smear." On March 13, 1995, the smear evaluation confirmed that Armstrong's white blood cell count was low and showed that her blood cells were "atypical, but not leukemic." While Dr. Perry suggested no immediate action as a result of the test results, she encouraged Armstrong to return for a "well-woman examination" in September 1995.
Armstrong saw Dr. Mark Davidner, an oncologist, on June 15, 1995, two weeks after her Aetna coverage began. Dr. Davidner examined Armstrong, finding signs of leukemia. A bone marrow aspiration on June 27th resulted in a definitive diagnosis of leukemia. Armstrong subsequently received treatment for leukemia through chemotherapy and a bone marrow transplant.
Armstrong sought coverage from Aetna for her leukemia treatment. Aetna initially indicated that Armstrong's policy covered the treatment but subsequently limited her coverage based on the "preexisting condition" provision in the health plan. The plan defines a preexisting condition as a condition that was diagnosed or treated, or for which treatment or services were received, or prescription drugs or medicines were prescribed or taken within 180 days of the date coverage became effective. (Appellant's App. at 92.) The plan limits benefits for treatment of a preexisting condition within the first year of coverage to $4,000. Armstrong appealed Aetna's determination that her claim fell under the preexisting condition limitation. Aetna reaffirmed its decision because Armstrong had received a service for leukemia within the previous six months when Dr. Perry conducted her examination of Armstrong.
Armstrong appealed Aetna's determination to the district court. Armstrong argued that the court should review Aetna's decision de novo because Aetna's role as both insurer and administrator of the plan created a conflict of interest. Moreover, she claimed that the incentives Aetna provided to its claim evaluators to deny benefits further justified heightened review by the court. Armstrong then argued that Missouri law should apply to her claim and that, under Missouri law, Aetna's preexisting condition provision is invalid. Armstrong alternatively argued that she did not have a "condition" within the meaning of the policy. The court determined that Aetna's decision was subject to an abuse-of-discretion standard, Delaware law applied to Armstrong's claim, and substantial evidence supported Aetna's decision that Armstrong had a preexisting condition. Armstrong appeals the district court's ruling and we affirm.
II.
A. Standard of Review
We review a decision by an ERISA plan administrator or fiduciary for an abuse of discretion if the plan specifically gives the administrator or fiduciary the authority to construe the terms of the plan. Firestone Tire & Rubber Co. v. Bruch,
We hold that the circumstances of this case require us to review Aetna's decision to deny benefits de novo. We are informed by the reasoning of the Eleventh Circuit's holding in Brown, which stated that a relationship that places an ERISA benefits plan administrator in "perpetual conflict" warrants a higher level of scrutiny. Brown,
Armstrong argued below that Delaware law applies to her claim. She now argues that Missouri law applies. Although we generally need not consider arguments raised for the first time on appeal, see Ryder v. Morris,
C. Aetna's Decision to Deny Benefits
We now turn to whether Armstrong is entitled to benefits. Armstrong contends that because her leukemia was in remission during the 180-day period prior to her coverage, she did not have a preexisting condition under the terms of the plan. Under the terms of the plan, however, if a plan participant receives treatment or a service for a condition within the 180 days prior to when coverage began, the plan limits benefits. Armstrong did not contest below, nor does she do so now, that the testing she received was a "service" within the meaning of the plan. Therefore, we accept that she received such a service. See Ryder,
The district court determined that sufficient evidence supported a finding that Armstrong had leukemia prior to the commencement of her coverage under the plan. Because that inquiry is not relevant under the terms of the plan, we need not consider the propriety of the district court's conclusion. Under the Aetna plan, a "preexisting condition" is a condition for which services or treatment were rendered within the 180-day period preceding coverage regardless of whether the condition manifested itself during that period. Armstrong received a service for leukemia during the 180-day period, and leukemia is a condition under the terms of the plan. She therefore is only entitled to benefits for the treatment of that condition as devised in the plan for a preexisting condition.
III.
For the foregoing reasons, the decision of the district court to grant Aetna's motion for summary judgment and deny Armstrong's motion for summary judgment is affirmed.
BEAM, Circuit Judge, concurring and, in part, dissenting.
I concur in the result reached by the court. I disagree, however, with the conclusions reached in Part IIA of the opinion on the standard of review. Thus, in part, I dissent.
The holding "that the circumstances of this case require us to review Aetna's decision to deny benefits de novo" is, essentially, obiter dictum. Ante at 1265. This is because under any standard of review the district court's decision must be affirmed given the interpretation we place on the words of the employer's plan insured by Aetna. Accordingly, we are not at all required to establish a review standard in this case and we should not do so under these particular circumstances since the issue appears to be a matter of first impression in this circuit.
Even assuming that our decision calls for the establishment of a standard of review, the de novo standard adopted is directly contrary to Supreme Court precedent established in Firestone Tire & Rubber Co. v. Bruch,
I can find no other circuit that presently applies a de novo review under the circumstances of this or any similar case. In establishing this de novo standard, the court asserts that it is "informed" by the reasoning of the Eleventh Circuit in Brown v. Blue Cross & Blue Shield,
While de novo review is an attractive avenue for controlling the exercise of discretion contrary to the interests of the beneficiaries, the application of this strict standard would deny Blue Cross the benefit of the bargain it made in the insurance contract.
Id. In short, Brown does not support the proposition for which it is advanced by the court. Indeed, no case that I have discovered does so.
Accordingly, while I concur in the result reached by the court, I disagree with its decision to establish a de novo standard of review for this circuit in this case of first impression.
Notes
Judge Fagg, Judge Wollman, Judge Beam, and Judge Loken would grant the motion
We have addressed the question of whether a variation of the abuse of discretion should apply where a "procedural irregularity" occurred in a plan administrator's determination of availability of benefits. See Wald v. Southwestern Bell Customcare Med. Plan,
The conflict in Firestone Tire resulted from Firestone being both the sole source of funding for and the administrator of the ERISA plans at issue while in this case Aetna is both the benefits insurer and the plan administrator. For our purposes in applying Firestone Tire, this is a distinction without a difference. Indeed, since we know nothing of the premium arrangement between Armstrong's employer and Aetna, it is possible, if not likely, that Firestone had a more intense conflict of interest than does Aetna in this matter
